CD8A and breast carcinoma: According to research by Sun L et al., in a 4T1 breast cancer mouse model, the number of CD8+ cytotoxic T cells in the tumor tissue of the MPLA + IFNγ combination treatment group increased significantly, with the infiltration density approximately more than 2-fold higher than the control group (untreated).